Cardiometabolic Syndrome

The term “Metabolic Syndrome” is generally used to indicate a clinical entity of substantial heterogeneity, represented by the co-occurrence of hypertension, impaired glucose tolerance, atherogenic dyslipidemia, central fat accumulation, insulin resistance, as well as prothrombotic and inflammatory states[1]. This multiple metabolic and cardiovascular disorders clusters together in the same individual more often than might be expected by chance, leading to an increased probability of suffering from cardiovascular disease and type 2 diabetes mellitus[2], [3].